Natural history of LGMD2A for delineating outcome measures in clinical trials

  1. Richard, I.
  2. Hogrel, J.-Y.
  3. Stockholm, D.
  4. Payan, C.A.M.
  5. Fougerousse, F.
  6. Eymard, B.
  7. Mignard, C.
  8. Lopez de Munain, A.
  9. Fardeau, M.
  10. Urtizberea, J.A.
Journal:
Annals of Clinical and Translational Neurology

ISSN: 2328-9503

Year of publication: 2016

Volume: 3

Issue: 4

Pages: 248-265

Type: Article

DOI: 10.1002/ACN3.287 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus